← Dashboard

Compliance Alert: Ozempic

Configure Methodology
--
Pending

This brand is pending video acquisition. Analysis will begin once the promotional video is uploaded and indexed.

Ozempic | Novo Nordisk Inc. | DTC Broadcast
FDA Letter May 22, 2026
--
Master
--
Visual
30%
--
Efficacy
25%
--
Fair Balance
20%
--
Adeq Prov
15%
--
Lifecycle
10%
!
FDA Enforcement Action on File
FDA Letter Feb 26, 2026 View PDF →

Recommendations

high
Escalate to regulatory affairs: FDA enforcement letter on file (Feb 26, 2026). Verify remediation status in PromoMats and confirm all content modifications address cited violations before next distribution.

Powered by cQuenced